Clinical Trials Logo

MILD TO SEVERE ACNE VULGARIS clinical trials

View clinical trials related to MILD TO SEVERE ACNE VULGARIS.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01257906 Completed - Clinical trials for MILD TO SEVERE ACNE VULGARIS

Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo

Start date: May 2010
Phase: N/A
Study type: Interventional

ZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) gel, marketed by Medicis, The Dermatology Company®, is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of clindamycin phosphate (1.2%) and tretinoin (0.025%) topical gel and the current study is designed to evaluate the bioequivalence of this formulation to ZIANA®.